Company profile
NanoPhoria
Pioneering INHALABLE CARDIOVASCULAR TREATMENTS via NON-VIRAL, NANO-IN-MICRO DELIVERY OF BIOLOGICS
- Industry
- Biotechnology
- Employees
- 17
- Headquarters
- Milan, Lombardy
- Founded
- 2022
- LinkedIn followers
- 2,403
- Office locations
- 1
NanoPhoria company summary
NanoPhoria is a company in the Biotechnology industry, headquartered in Milan, Lombardy, founded in 2022. On LinkedIn the company has around 17 employees and 2,403 followers.
What technology does NanoPhoria use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About NanoPhoria
NanoPhoria is a preclinical stage biotech company pioneering inhalable cardiovascular treatments via non-viral nano-delivery of biologics. The Company is devoted to the clinical development of an innovative proprietary platform for the tissue-directed delivery of therapeutic peptides and RNAs. The core vehicle is an inorganic calcium-phosphate nanoparticle which represents a versatile, biomimetic nano-carrier that can be loaded or surface decorated with biologics and can be formulated for inhalation or for other administration routes. NanoPhoria’s lead product, NP-MP1 is an inhalable nano-in-micro formulation, delivering a proprietary peptide, first-in-class calcium channel modulator, for the treatment of Heart Failure with reduced Ejection Fraction, a chronic syndrome affecting the lives of millions worldwide.
Where is NanoPhoria located?
NanoPhoria lists 1 location.
Compare companies similar to NanoPhoria
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
NanoPhoria nanophoria.com | Biotechnology | 17 | 2022 | Milan, Lombardy |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about NanoPhoria
What does NanoPhoria do?
NanoPhoria is a preclinical stage biotech company pioneering inhalable cardiovascular treatments via non-viral nano-delivery of biologics. The Company is devoted to the clinical development of an innovative proprietary platform for the tissue-directed delivery of therapeutic peptides and RNAs. The core vehicle is an inorganic calcium-phosphate nanoparticle which represents a versatile, biomimetic nano-carrier that can be loaded or surface decorated with biologics and can be formulated for inhalation or for other administration routes. NanoPhoria’s lead product, NP-MP1 is an inhalable nano-in-micro formulation, delivering a proprietary peptide, first-in-class calcium channel modulator, for the treatment of Heart Failure with reduced Ejection Fraction, a chronic syndrome affecting the lives of millions worldwide.
How many employees does NanoPhoria have?
NanoPhoria has around 17 employees on LinkedIn.
Where is NanoPhoria headquartered?
NanoPhoria is headquartered in Milan, Lombardy.
When was NanoPhoria founded?
NanoPhoria was founded in 2022.
Build a lead list from companies like NanoPhoria
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.